Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenoFAB
Fort Collins, Colorado, United States
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
GenoFAB's self-documenting plasmid technology (GSIN) enables DNA constructs to be traceable, verifiable, and licenseable. The company is commercially distributing advanced plasmid and genetic construct design and production services, with reported technical validation of GSIN for both bacterial propagation and mammalian expression, and active collaborations with academic and industrial partners[4][5].
- Modalities
- PlasmidRecombinant DNASynthetic biology tools
- Industry
- Non-Drug Biotech
02
Partnerships
Decisions LLCBioMADEColorado State UniversityVirginia Tech
Beyond the preview
Go deeper on GenoFAB.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GenoFAB.